# Bioequivalence Study of Furosemide 40 mg Tablet in 24 Indonesian Healthy Volunteers

> **NCT04982874** · NA · COMPLETED · sponsor: **PT. Kimia Farma (Persero) Tbk** · enrollment: 24 (actual)

## Conditions studied

- Drug Use

## Interventions

- **DRUG:** Furosemide 40 mg
- **DRUG:** Lasix® 40 mg Tablet

## Key facts

- **NCT ID:** NCT04982874
- **Lead sponsor:** PT. Kimia Farma (Persero) Tbk
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-13
- **Primary completion:** 2020-01-17
- **Final completion:** 2020-01-29
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04982874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04982874, "Bioequivalence Study of Furosemide 40 mg Tablet in 24 Indonesian Healthy Volunteers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04982874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*